Cobaltous Chloride
drug drugOn this page
Also known as Cobalt chlorideCobalt chloride (cocl2)Cobalt dichloride (cocl2)Cobaltous dichlorideCobaltum muriaticumNSC-51149Cobalt (II) Chloride
Summary
Cobaltous Chloride (CHEMBL1909055) is an approved small molecule.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Small molecule
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1909055 |
| Name | Cobaltous Chloride |
| Type | Small molecule |
| Max phase | 4 |
Also known as: Cobalt chloride, Cobalt chloride (cocl2), Cobalt dichloride (cocl2), Cobaltous dichloride, Cobaltum muriaticum, NSC-51149, Cobalt (II) Chloride, COBALT (II) CHLORIDE, Cobalt Chloride, Cobalt (II) chloride
Parent form; salt/anhydrous children: CHEMBL1200529, CHEMBL1201094
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.